- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05892419
Electrophysiological Signatures of Distinct Working Memory Subprocesses That Predict Long-term Memory Success (WMLTM)
June 7, 2023 updated by: University of Chicago
Healthy young adults will view pictures of items while the investigators record electroencephalogram (EEG) brain activity.
Then, the investigators will ask the participants to report which items the participants remember seeing.
The investigators will examine how the measured brain activity relates to which pictures the participants remember.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Detailed Description
Electrophysiological signatures track distinct subprocesses of working memory, including the number of items and the spatial locations of those items.
By identifying how these subprocesses predict long-term memory success in healthy young adults, this project should lead to an intricate understanding of the relationship between working memory and long-term memory.
This study will investigate when and how long-term memory failures arise, by using sophisticated machine learning analyses of neural data.
Moreover, this study will test the extent to which the investigators can track working memory processes in real time and how the investigators can leverage that information to improve long-term memory success.
This will inform basic theories of the relationship between working memory and long-term memory and motivate future applications.
Study Type
Observational
Enrollment (Estimated)
96
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Healthy young adults
Description
Inclusion Criteria:
- normal or corrected to normal vision
Exclusion Criteria:
- non-fluent in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Memory performance
Time Frame: This task is performed multiple time within the experimental session, which in total lasts around 3 hours.
|
To measure recognition memory performance, participants will view pictures and respond as to whether they remember previously seeing these items.
Participants will be shown both old and new items.
In the long-term memory phase, they will report their confidence at having seen each image using a four point rating scale, ranging from being confident the item is new (i.e., not previously seen) to being confident the item is old (i.e., previously seen).
|
This task is performed multiple time within the experimental session, which in total lasts around 3 hours.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Megan deBettencourt, University of Chicago
- Principal Investigator: Ed Vogel, University of Chicago
- Principal Investigator: Ed Awh, University of Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Estimated)
July 31, 2024
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
May 26, 2023
First Submitted That Met QC Criteria
May 26, 2023
First Posted (Actual)
June 7, 2023
Study Record Updates
Last Update Posted (Actual)
June 9, 2023
Last Update Submitted That Met QC Criteria
June 7, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- IRB15-1290
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The investigators will post de-identified data online on scientific repositories including the Open Science Framework (online), zenodo or github, so that anonymized data will be made available to outside researchers.
Shared data will include, at a minimum, csv or text files that summarize participants performance.
Any computer scripts or stimuli used for task development also will be shared.
IPD Sharing Time Frame
After publication, in perpetuity
IPD Sharing Access Criteria
The code and data will be freely available through online repositories.
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory
-
Kutahya Health Sciences UniversityCompletedWorking Memory | The Working Memory QuestionnaireTurkey
-
Prof. Dominique de Quervain, MDClinical Trial Unit, University Hospital Basel, SwitzerlandCompletedMemory, Short-Term | Memory, Long-TermSwitzerland
-
Dream Video LLCDream Holdings ResearchNot yet recruitingMemory | Habits | Behavior Change Interventions | Memory Encoding
-
EnzymedicaKGK Science Inc.CompletedMemory | Self-reported Memory ProblemsCanada
-
University of Electronic Science and Technology...CompletedOxytocin Effect on Memory Performance During Phase 1 | Oxytocin Effect on Memory Performance During Phase 2 | Oxytocin Effect on Memory Performance During Phase 3 | Oxytocin Effect on Memory Performance During Phase 4China
-
Memorial Sloan Kettering Cancer CenterCompletedMemory Losses | Amnesia-Memory LossUnited States
-
University of Maryland, College ParkUniversity of Massachusetts, AmherstRecruiting
-
Virginia Polytechnic Institute and State UniversityEnrolling by invitation
-
University of PennsylvaniaNational Institute of Mental Health (NIMH)Completed
-
Prof. Dominique de Quervain, MDCompleted
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown